We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.53B
1-Year Est. Return 154.61%
This Fund
S&P 500
This Quarter Est. Return
+20.44%
1 Year Est. Return
+154.61%
3 Year Est. Return
+564.07%
5 Year Est. Return
+985.88%
10 Year Est. Return
–
AUM
$476M
AUM Growth
-$38.3M
Cap. Flow
-$70.4M
Cap. Flow %
-14.78%
Top 10 Hldgs %
34.45%
Holding
94
New
29
Increased
20
Reduced
12
Closed
33

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$16.4M
2
DGX icon
Quest Diagnostics
DGX
+$14.4M
3
CI icon
Cigna
CI
+$14.2M
4
UHS icon
Universal Health Services
UHS
+$11.8M
5
ISRG icon
Intuitive Surgical
ISRG
+$10.7M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$16.2M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$14.4M
3
BSX icon
Boston Scientific
BSX
+$13.6M
4
BIIB icon
Biogen
BIIB
+$13.3M
5
CVS icon
CVS Health
CVS
+$12.4M

Sector Composition

Rank Sector Weight
1 Healthcare 93.11%
2 Miscellaneous 6.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
1
CALL
Cytokinetics
CYTK
$8.99B
$18.3M 3.85%
400,000
-56,300
-12% -$2.42M
CYTK icon
2
Cytokinetics
CYTK
$8.99B
$18.3M 3.85%
400,000
+50,000
+14% +$2.15M
MRNA icon
3
Moderna
MRNA
$79.4B
$18M 3.77%
+100,000
New +$16.4M
BMRN icon
4
BioMarin Pharmaceuticals
BMRN
$11.7B
$17.6M 3.69%
170,000
+63,000
+59% +$5.91M
MRK icon
5
Merck
MRK
$367B
$16.6M 3.49%
150,000
-35,000
-19% -$3.58M
DGX icon
6
Quest Diagnostics
DGX
$26.1B
$15.6M 3.28%
+100,000
New +$14.4M
INSP icon
7
Inspire Medical Systems
INSP
$2.04B
$15.1M 3.17%
60,000
+20,000
+50% +$4.26M
ZNTL icon
8
Zentalis Pharmaceuticals
ZNTL
$256M
$15.1M 3.17%
750,000
+200,000
+36% +$4.3M
CI icon
9
Cigna
CI
$71.9B
$14.9M 3.13%
+45,000
New +$14.2M
MDGL icon
10
PUT
Madrigal Pharmaceuticals
MDGL
$11.9B
$14.5M 3.05%
+50,000
New +$4.89M
UHS icon
11
Universal Health Services
UHS
$10.5B
$14.1M 2.96%
+100,000
New +$11.8M
SAGE
12
DELISTED
Sage Therapeutics
SAGE
$13.7M 2.88%
360,000
+3,000
+0.8% +$115K
EXAS
13
DELISTED
Exact Sciences
EXAS
$13.6M 2.86%
275,000
+125,000
+83% +$5.11M
GH icon
14
Guardant Health
GH
$23.8B
$12.9M 2.71%
475,000
+25,000
+6% +$1.14M
ELV icon
15
Elevance Health
ELV
$85.9B
$12.8M 2.69%
25,000
-15,000
-38% -$7.62M
QURE icon
16
uniQure
QURE
$2.65B
$12.5M 2.62%
550,000
+117,000
+27% +$2.52M
ISRG icon
17
Intuitive Surgical
ISRG
$143B
$11.7M 2.45%
+44,000
New +$10.7M
HCA icon
18
HCA Healthcare
HCA
$94.3B
$10.3M 2.17%
+43,000
New +$9.63M
GILD icon
19
Gilead Sciences
GILD
$187B
$10.3M 2.16%
+120,000
New +$9.5M
SNY icon
20
Sanofi
SNY
$98.5B
$9.69M 2.03%
200,000
-50,000
-20% -$2.19M
AZN icon
21
AstraZeneca
AZN
$258B
$9.49M 1.99%
+70,000
New +$8.78M
RLAY icon
22
Relay Therapeutics
RLAY
$3.83B
$9.34M 1.96%
625,000
+25,000
+4% +$479K
KRYS icon
23
Krystal Biotech
KRYS
$10.2B
$9.11M 1.91%
115,000
+25,000
+28% +$1.86M
ALNY icon
24
Alnylam Pharmaceuticals
ALNY
$34.2B
$8.32M 1.75%
35,000
-35,000
-50% -$7.47M
ZBH icon
25
Zimmer Biomet
ZBH
$17.4B
$8.29M 1.74%
+65,000
New +$7.54M
1
2 3 4

Similar funds

VWA
Visionary Wealth Advisors O'fallon, Illinois $2.53B AUM 24.4% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
AIM
Acropolis Investment Management St. Louis, Missouri $2.54B AUM 18.96% 1-Year Est. Return
QT
Quantbot Technologies New York $2.54B AUM 22.25% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.53B AUM 37.62% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.54B AUM 23.56% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.54B AUM 17.62% 1-Year Est. Return
IFA
Index Fund Advisors Irvine, California $2.52B AUM 26.26% 1-Year Est. Return

Integral Health Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Integral Health Asset Management held 94 positions worth $476M, down 7.4% from $515M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Integral Health Asset Management withdrew a net $70.4M in Q4 2022, closing 33 positions and reducing 12 holdings. Its most notable exit was Baxter International, an estimated $16.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 96% a quarter earlier, followed by Miscellaneous.

Against the trend, Integral Health Asset Management opened a new position in Moderna worth $18M.

  • Integral Health Asset Management's largest Q4 2022 buy was Moderna: 100,000 shares worth $18M.
  • Integral Health Asset Management added most to BioMarin Pharmaceuticals in Q4 2022, an estimated $5.91M increase.
  • Integral Health Asset Management's biggest Q4 2022 reduction was Envista, cutting an estimated $11.6M.
  • Integral Health Asset Management fully exited Baxter International in Q4 2022, selling an estimated $16.2M.
  • Integral Health Asset Management's ten largest holdings make up 34% of its $476M portfolio in Q4 2022.
  • Integral Health Asset Management opened 29 new positions and closed 33 in Q4 2022.
  • Integral Health Asset Management's portfolio value fell 7.4% quarter-over-quarter to $476M.

Based on Integral Health Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.